Manager TitleAgeSince
Director of Finance/CFO 48 01/10/2023
Chief Operating Officer - 01/02/2024
Investor Relations Contact - -
Director TitleAgeSince
Chairman 58 -
Director/Board Member 48 24/05/2022
Director/Board Member - 24/05/2022
Date Insider Type Main position Quantity % Market Cap.
24/05/22 Issuer sale

Director

9,121 0.0983%
24/05/22 Issuer sale

Chairman

26,327 0.2837%
24/05/22 Issuer sale

Director

11,154 0.1202%
Change 5-day change 1-year change 3-year change Capi.($)
+0.04%+0.21% - - 225M
+0.97%+10.37%-17.80%-9.09% 175B
+0.11%-0.34%-7.05%-6.78% 106B
-1.27%-0.70%+3.80%+57.17% 59.91B
+0.26%-1.13%+40.68%+60.97% 51.95B
-2.33%+0.42%-13.63%-41.35% 43.58B
-2.29%-4.19% - - 33.65B
-1.25%-0.86%-9.77%-42.07% 29.58B
-1.65%-2.05%+67.06%-6.98% 25.31B
-1.55%-1.19%-4.93%-6.81% 21.23B
Average -0.90%+0.88%+7.30%+0.63% 60.79B
Weighted average by Cap. -0.31%+3.25%-1.60%+1.77%
Logo IntriCon Corporation
Intricon Corporation is a joint development manufacturer (JDM) of micro medical components, sub-assemblies and final devices. The Company serves as a JDM partner to medical device original equipment manufacturers (OEMs) by designing, developing, engineering, manufacturing, packaging and distributing micro medical devices components and subassemblies for medical markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. It manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and complete catheter-based and body-worn devices for medical device manufacturers. The Company serves its market by offering medical device manufacturers, which have the capabilities to design, develop, manufacture, package and distribute medical devices. It operates globally with facilities in Minnesota, Illinois, California, Singapore, Indonesia and Germany.
Employees
873